IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v20y2023i1p848-d1022922.html
   My bibliography  Save this article

Prevalence and Associated Factors of Post-COVID-19 Syndrome in a Brazilian Cohort after 3 and 6 Months of Hospital Discharge

Author

Listed:
  • Juliana Lapa

    (Núcleo de Medicina Tropical, Faculdade de Medicina, Universidade de Brasília, Campus Universitário Darcy Ribeiro, Asa Norte, Brasília 70910-900, Brazil)

  • Davi Rosa

    (Núcleo de Medicina Tropical, Faculdade de Medicina, Universidade de Brasília, Campus Universitário Darcy Ribeiro, Asa Norte, Brasília 70910-900, Brazil)

  • João Pedro Lima Mendes

    (Núcleo de Medicina Tropical, Faculdade de Medicina, Universidade de Brasília, Campus Universitário Darcy Ribeiro, Asa Norte, Brasília 70910-900, Brazil)

  • Rodolfo Deusdará

    (Núcleo de Medicina Tropical, Faculdade de Medicina, Universidade de Brasília, Campus Universitário Darcy Ribeiro, Asa Norte, Brasília 70910-900, Brazil)

  • Gustavo Adolfo Sierra Romero

    (Núcleo de Medicina Tropical, Faculdade de Medicina, Universidade de Brasília, Campus Universitário Darcy Ribeiro, Asa Norte, Brasília 70910-900, Brazil
    Instituto de Avaliação de Tecnologia em Saúde, Ramiro Barcelos Street, 2350, Santa Cecília, Porto Alegre, RS, Brasília 90035-903, Brazil)

Abstract

(1) Objectives: To evaluate the frequency and factors associated with the Post-COVID-19 Syndrome (PCS) in COVID-19 survivors after 3 and 6 months of hospital discharge; (2) Methods: We conducted a cohort study with patients who were hospitalized with COVID-19 in a referral public hospital in Brasília, Federal District, Brazil. After 3 and 6 months of discharge, patients answered a questionnaire about PCS symptoms. Poisson regression with robust variance was used to estimate the crude and adjusted prevalence ratios (PR and aPR) of PCS. (3) Results: The prevalence of PCS was 81% and 61% after 3 and 6 months of hospital discharge, respectively. The main symptoms after 3 months of discharge were hair loss (44%), fatigue (42%), and memory loss (39%); while after 6 months, they were memory loss (29%) and fatigue (27%). In the multivariate analysis, the main factor associated with PCS was female gender (aPR): 1.28 (1.16–1.41) and 1.60 (1.34–1.90), 3 and 6 months after hospital discharge, respectively. Hypercholesterolemia was also associated with PCS after 3 months aPR of 1.15 (1.04–1.27). After 6 months of discharge, obesity [aPR: 1.22 (1.03–1.45)] and pronation [aPR: 1.15 (1.06–1.25)] were relevant associated factors. (4) Conclusions: The prevalence of PCS was high in COVID-19 survivors who had the moderate and severe forms of the disease. Memory loss was the most persistent symptom. Our data pointed to female gender, hypercholesterolemia, obesity, and pronation during hospitalization as relevant PCS-associated risk factors.

Suggested Citation

  • Juliana Lapa & Davi Rosa & João Pedro Lima Mendes & Rodolfo Deusdará & Gustavo Adolfo Sierra Romero, 2023. "Prevalence and Associated Factors of Post-COVID-19 Syndrome in a Brazilian Cohort after 3 and 6 Months of Hospital Discharge," IJERPH, MDPI, vol. 20(1), pages 1-12, January.
    • Handle: RePEc:gam:jijerp:v:20:y:2023:i:1:p:848-:d:1022922
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/20/1/848/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/20/1/848/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Takehiro Takahashi & Mallory K. Ellingson & Patrick Wong & Benjamin Israelow & Carolina Lucas & Jon Klein & Julio Silva & Tianyang Mao & Ji Eun Oh & Maria Tokuyama & Peiwen Lu & Arvind Venkataraman & , 2020. "Sex differences in immune responses that underlie COVID-19 disease outcomes," Nature, Nature, vol. 588(7837), pages 315-320, December.
    2. Eric Y. Wang & Tianyang Mao & Jon Klein & Yile Dai & John D. Huck & Jillian R. Jaycox & Feimei Liu & Ting Zhou & Benjamin Israelow & Patrick Wong & Andreas Coppi & Carolina Lucas & Julio Silva & Ji Eu, 2021. "Diverse functional autoantibodies in patients with COVID-19," Nature, Nature, vol. 595(7866), pages 283-288, July.
    3. Matthew C. Woodruff & Richard P. Ramonell & Natalie S. Haddad & Fabliha A. Anam & Mark E. Rudolph & Tiffany A. Walker & Alexander D. Truong & Adviteeya N. Dixit & Jenny E. Han & Monica Cabrera-Mora & , 2022. "Dysregulated naive B cells and de novo autoreactivity in severe COVID-19," Nature, Nature, vol. 611(7934), pages 139-147, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Sunil K. Ahuja & Muthu Saravanan Manoharan & Grace C. Lee & Lyle R. McKinnon & Justin A. Meunier & Maristella Steri & Nathan Harper & Edoardo Fiorillo & Alisha M. Smith & Marcos I. Restrepo & Anne P. , 2023. "Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection," Nature Communications, Nature, vol. 14(1), pages 1-31, December.
    2. Hideki Ogura & Jin Gohda & Xiuyuan Lu & Mizuki Yamamoto & Yoshio Takesue & Aoi Son & Sadayuki Doi & Kazuyuki Matsushita & Fumitaka Isobe & Yoshihiro Fukuda & Tai-Ping Huang & Takamasa Ueno & Naomi Mam, 2022. "Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    3. Shelly J. Robertson & Olivia Bedard & Kristin L. McNally & Carl Shaia & Chad S. Clancy & Matthew Lewis & Rebecca M. Broeckel & Abhilash I. Chiramel & Jeffrey G. Shannon & Gail L. Sturdevant & Rebecca , 2023. "Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    4. Simona Bignami-Van Assche & Daniela Ghio, 2022. "Comparing COVID-19 fatality across countries: a synthetic demographic indicator," Journal of Population Research, Springer, vol. 39(4), pages 513-525, December.
    5. Dominik Menges & Kyra D. Zens & Tala Ballouz & Nicole Caduff & Daniel Llanas-Cornejo & Hélène E. Aschmann & Anja Domenghino & Céline Pellaton & Matthieu Perreau & Craig Fenwick & Giuseppe Pantaleo & C, 2022. "Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    6. August F. Jernbom & Lovisa Skoglund & Elisa Pin & Ronald Sjöberg & Hanna Tegel & Sophia Hober & Elham Rostami & Annica Rasmusson & Janet L. Cunningham & Sebastian Havervall & Charlotte Thålin & Anna M, 2024. "Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    7. Brent Appelman & Braeden T. Charlton & Richie P. Goulding & Tom J. Kerkhoff & Ellen A. Breedveld & Wendy Noort & Carla Offringa & Frank W. Bloemers & Michel Weeghel & Bauke V. Schomakers & Pedro Coelh, 2024. "Muscle abnormalities worsen after post-exertional malaise in long COVID," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
    8. Weirong Chen & So-Hee Hong & Scott A. Jenks & Fabliha A. Anam & Christopher M. Tipton & Matthew C. Woodruff & Jennifer R. Hom & Kevin S. Cashman & Caterina Elisa Faliti & Xiaoqian Wang & Shuya Kyu & C, 2024. "Distinct transcriptomes and autocrine cytokines underpin maturation and survival of antibody-secreting cells in systemic lupus erythematosus," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    9. Otavio Cabral-Marques & Gilad Halpert & Lena F. Schimke & Yuri Ostrinski & Aristo Vojdani & Gabriela Crispim Baiocchi & Paula Paccielli Freire & Igor Salerno Filgueiras & Israel Zyskind & Miriam T. La, 2022. "Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    10. Peter Radvak & Hyung-Joon Kwon & Martina Kosikova & Uriel Ortega-Rodriguez & Ruoxuan Xiang & Je-Nie Phue & Rong-Fong Shen & James Rozzelle & Neeraj Kapoor & Taylor Rabara & Jeff Fairman & Hang Xie, 2021. "SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    11. Jakob Ankerhold & Sebastian Giese & Philipp Kolb & Andrea Maul-Pavicic & Reinhard E. Voll & Nathalie Göppert & Kevin Ciminski & Clemens Kreutz & Achim Lother & Ulrich Salzer & Wolfgang Bildl & Tim Wel, 2022. "Circulating multimeric immune complexes contribute to immunopathology in COVID-19," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    12. Jia Wei & Philippa C. Matthews & Nicole Stoesser & Thomas Maddox & Luke Lorenzi & Ruth Studley & John I. Bell & John N. Newton & Jeremy Farrar & Ian Diamond & Emma Rourke & Alison Howarth & Brian D. M, 2021. "Anti-spike antibody response to natural SARS-CoV-2 infection in the general population," Nature Communications, Nature, vol. 12(1), pages 1-12, December.
    13. Viet-Thi Tran & Raphaël Porcher & Isabelle Pane & Philippe Ravaud, 2022. "Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort," Nature Communications, Nature, vol. 13(1), pages 1-6, December.
    14. Matthew C. Woodruff & Kevin S. Bonham & Fabliha A. Anam & Tiffany A. Walker & Caterina E. Faliti & Yusho Ishii & Candice Y. Kaminski & Martin C. Ruunstrom & Kelly Rose Cooper & Alexander D. Truong & A, 2023. "Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    15. André Santa Cruz & Ana Mendes-Frias & Marne Azarias-da-Silva & Sónia André & Ana Isabel Oliveira & Olga Pires & Marta Mendes & Bárbara Oliveira & Marta Braga & Joana Rita Lopes & Rui Domingues & Ricar, 2023. "Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8+β7 integrin+ T cells and anti-SARS-CoV-2 IgA response," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    16. Danielsen, Ann Caroline & Lee, Katharine MN & Boulicault, Marion & Rushovich, Tamara & Gompers, Annika & Tarrant, Amelia & Reiches, Meredith & Shattuck-Heidorn, Heather & Miratrix, Luke W. & Richardso, 2022. "Sex disparities in COVID-19 outcomes in the United States: Quantifying and contextualizing variation," Social Science & Medicine, Elsevier, vol. 294(C).
    17. Jillian R. Jaycox & Carolina Lucas & Inci Yildirim & Yile Dai & Eric Y. Wang & Valter Monteiro & Sandra Lord & Jeffrey Carlin & Mariko Kita & Jane H. Buckner & Shuangge Ma & Melissa Campbell & Albert , 2023. "SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity," Nature Communications, Nature, vol. 14(1), pages 1-9, December.
    18. Rúbens Prince dos Santos Alves & Julia Timis & Robyn Miller & Kristen Valentine & Paolla Beatriz Almeida Pinto & Andrew Gonzalez & Jose Angel Regla-Nava & Erin Maule & Michael N. Nguyen & Norazizah Sh, 2024. "Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    19. Abdulaziz Alqahtani & Edrous Alamer & Mushtaq Mir & Ali Alasmari & Mohammed Merae Alshahrani & Mohammed Asiri & Irfan Ahmad & Abdulaziz Alhazmi & Abdullah Algaissi, 2022. "Bacterial Coinfections Increase Mortality of Severely Ill COVID-19 Patients in Saudi Arabia," IJERPH, MDPI, vol. 19(4), pages 1-11, February.
    20. Nathália Mariana Santos Sansone & Letícia Rogini Pereira & Matheus Negri Boschiero & Felipe Eduardo Valencise & Andréa Melo Alexandre Fraga & Fernando Augusto Lima Marson, 2022. "Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pand," IJERPH, MDPI, vol. 19(15), pages 1-20, July.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:20:y:2023:i:1:p:848-:d:1022922. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.